Phase II trial of sorafenib (BAY 43-9006) in malignant mesothelioma: CALGB 30307 Meeting Abstract


Authors: Jänne, P. A.; Wang, X. F.; Krug, L. M.; Hodgson, L.; Vokes, E. E.; Kindler, H. L.
Abstract Title: Phase II trial of sorafenib (BAY 43-9006) in malignant mesothelioma: CALGB 30307
Meeting Title: 8th International Congress of the International Mesothelioma Interest Group
Journal Title: Lung Cancer
Volume: 54
Issue: Suppl.1
Meeting Dates: 2006 Oct 19-22
Meeting Location: Chicago, IL
ISSN: 0169-5002
Publisher: Elsevier Ireland Ltd.  
Date Published: 2006-10-01
Start Page: S51
End Page: S52
Language: English
ACCESSION: WOS:000241900400211
DOI: 10.1016/s0169-5002(07)70287-8
PROVIDER: wos
Notes: --- - Meeting Abstract: 211 - "1" - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lee M Krug
    178 Krug